DailyTimeCapsule brief
February 26, 2004
On February 26, 2004, Mel Gibson's film, 'The Passion of the Christ,' was creating significant buzz, but concerns arose that the intense scrutiny and controversy surrounding it could adversely impact his career. The film, which had sparked heated debates over its portrayal of biblical events, was slated for release soon, highlighting tensions in Hollywood regarding religious themes. In the pharmaceutical sector, two cancer drugs were introduced into the market, yet they lacked comparative data, raising concerns among medical professionals about their effectiveness. Meanwhile, in the business world, Softbank shares were affected by recent arrests, reflecting broader economic uncertainties in Japan, as the company was grappling with regulatory issues and investor confidence. This date encapsulated a blend of cultural and economic tensions, highlighting both the controversies in entertainment and the critical landscape of medicine and business in Asia.
Key developments
-
Mel Gibson's upcoming film, The Passion of the Christ, has sparked significant backlash from prominent Hollywood actors and figures due to its controversial themes and perceived anti-Semitic undertones. Many colleagues in the industry, both Jewish and non-Jewish, are voicing concerns about their uncomfortable feelings towards the film and Gibson's refusal to publicly distance himself from his father, Hutton, who has made anti-Semitic statements. This backlash threatens to damage Gibson's reputation and career in an industry that values sensitivity to social issues.
-
In a significant move, Congress added a provision to Medicare legislation that prevents the direct comparison of efficacy between Amgen's Aranesp and Johnson & Johnson's Procrit. This decision came after lobbying efforts by pharmaceutical industry representatives, undermining the potential to determine which drug provides better outcomes for cancer patients. As a result, Medicare's planned evaluation of these two cancer treatments has become ineffective, raising concerns about drug pricing and patient care.
-
Shares of Softbank Corp experienced a significant decline after Japanese authorities detained four individuals suspected of attempting to extort the company. These suspects allegedly acquired personal data pertaining to approximately 4.6 million subscribers of Softbank's Yahoo BB broadband Internet service. The incident has raised concerns about data security and corporate integrity, impacting investor confidence in the technology giant.
